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Pulmonary thromboembolism (PT E) 
Tony Glaus, Prof. Dr. med. Vet., Dipl. ACVIM and ECVIM-CA, Head Division of 
Cardiology, Vetsuisse Faculty University of Zurich, CH-8057 Zurich 
 
Definitions  
Thrombosis is the local formation of a thrombus inside a vessel leading to vascular 
occlusion, embolism is the vascular occlusion by various formations like a thrombus, 
tissue particle, parasite, foreign body, tumor cells or air that have been formed distant to 
the actual occlusion and that are carried in the vessel to the site of occlusion, and 
thromboembolism is thus the vascular occlusion specifically by a thrombus that was 
not produced at the site of occlusion but carried there. Once a thrombus is present in the 
circulation it may grow. In this text, the abbreviation PTE will be used to describe both 
pulmonary artery thrombosis and / or embolism and / or thromboembolism.  
 
Pathogenesis  
For PTE to occur, an important disturbance in the very delicate balance between pro- 
and antithrombotic body systems has to be present, i.e. there may be excessive 
abnormal focal vascular triggers of coagulation, a systemic hypercoagulable state, or a 
systemic hypofibrinolytic state.  
 
Diagnosis 
Pulmonary thromboembolism (PTE) in dogs is probably underdiagnosed. Its presence 
may be suspected in patients with documented hypoxemia or hypercarbia, affected with 
a disease with known risk for PTE, coagulation abnormalities, suspicious radiographic 
findings, and the echocardiographic recognition of pulmonary hypertension (PH). 
Depending on the severity of PTE however, arterial oxygen content, routine coagulation 
parameters (PT, PTT, TT), thoracic radiographs and echocardiography may be 
unremarkable.  
Likewise, the clinical abnormalities are quite variable and may range from 
asymptomatic to mild cough, exercise intolerance, right sided heart failure, severe 
dyspnea to quite unexpected death. The clinical abnormalities depend on the underlying 
cause as well as on the extent of the thrombosis.  
Not only severe and symptomatic PTE is a life threatening condition, but also mild and 
subclinical PTE is dangerous, because it may progress to severe PTE. 
Probably the most important diagnostic clue to detect PT E is a high index of 
suspicion. Important diseases with known risk for PTE include  
- autoimmune hemolytic anemia 
- hyperadrenocorticism 
- nephrotic syndrome 
- severe pancreatitis 
- septicemia 
- cancer 
- pulmonary artery parasites and vasculitis (Dirofilaria immitis, Angiostrongylus 
vasorum) 
Thus, if one of these diseases is known to be present, also PTE must be considered to be 
present or to develop, and dogs affected with one of these conditions have to be closely 
monitored for signs suspicious for PTE. 
 
Experimental findings on test performance in PT E 
Angiostrongylus (A.) vasorum infection in experimentally infected dogs consistently 
causes pulmonary artery lesions with PTE at the time of patency, and in naturally 
infected dogs has been shown to sometimes cause severe PH. Experimental infection of 
A. vasorum allows to study the effects of PTE on various above mentioned parameters 
in a well defined system. Some of the findings shall be described below. 
In one study, 3 healthy Beagles were experimentally infected with 50 and 3 with 500 
larvae. Clinical and fecal Baermann examinations were done daily. Thoracic 
radiographs and femoral arterial blood gas analyses were performed 8 and 13 weeks (w) 
post infection (pi), and 9w post therapy (pt). Echocardiography was done at time 0 and 
2, 5, 8, 13wpi, and 9 wpt. Invasive pulmonary artery pressure (PAP) measurements 
under sedation were obtained 8 wpi. Four dogs were treated with a parasiticide at 13 
wpi. The prepatent period lasted 47-49 days, and around the same time (42-56 days pi) 
the first respiratory signs were observed. Radiographic abnormalities were marked at 8 
wpi with obvious progression to 13 wpi; besides pulmonary parenchymal lesions, 
several dogs developed pleural effusion. The pulmonary lesions were paralleled by 
moderate hypoxemia with a median PO2 of 73 and 74 mmHg at 8 and 13 w pi, 
respectively. No 2D, M-Mode or Doppler echocardiographic changes including Tei-
index were observed at 2, 5, 8 and 13 w pi. No relevant PH was discernible at any time; 
median calculated RV-RA-gradients were 24 mmHg at time 0, and ranged between 19 
and 24 mmHg at the different time points pi and pt. Invasive PAP measurements at 
8wpi revealed median sPAP and dPAP of 31 and 15 mmHg, respectively. Radiographic 
lung changes and blood gas abnormalities correlated with clinical signs, but not with 
echocardiographic findings. Four of the 6 dogs were treated, and 9 wpi the radiographic 
abnormalities had mostly resolved, leaving only a mild interstitital pattern. Upon 
necropsy in 2 untreated dogs (infected with 50 and 500 larvae) subjectively the lungs 
were similarly affected and estimated to be around 80% abnormal. Histological lesions 
included severe inflammation, hemorrhage and thrombosis. In the four treated dogs, 
there was still evidence of thrombosis at the time of necropsy, 9wpt. The mentioned 
interstitial pattern on radiographs in these was due to fibrosis. In this study, marked 
pulmonary changes in A. vasorum infection were not associated with abnormalities in 
cardiac function using conventional routine echogcardiograpy and did not cause 
measurable PH. It was concluded that relevant PH may only develop at the time of acute 
and more severe pulmonary thrombosis. It was further speculated that newer ultrasound 
techniques might be more sensitive to detect changes in right ventricular function in 
face of marked pulmonary disease. 
The same 6 dogs were also examined by computed tomography to characterize the 
pulmonary lesions more exactly than with routine radiographs. Contrast CT was 
expected to help identifying arterial thrombosis. A first CT was done 13 weeks post 
infection (wpi) in all, and a second 9 weeks after treatment (wpt) in 4 dogs. CareDose 
was used to choose mA automatically as low as possible. Scanning parameters were 120 
kV and a pitch of 1.2. Rotation time was 1 second. The images were reconstructed in 
1.5 mm slices. The post contrast scan was done 20 seconds after administration of 
Telebrix?35 (2.5ml/s, 2 ml/kg BW). At 13 wpi, severe consolidations with 
airbronchograms, large nodules and extensive areas of ground glass opacifications were 
found in the periphery of all lung lobes. Bronchi and lymph nodes were normal. Mild 
pleural effusion was found in five dogs. Post contrast CT revealed abruptly stopping 
vessels. At 9 wpt the consolidations, large nodules, pleural effusion and vascular 
abnormalities had resolved. Mild interstitial opacifications, subpleural interstitial 
thickening, subpleural lines and interface signs could still be observed, independent of 
the severity of the infection. In the very periphery of the airways slight bronchial 
dilatation could now be identified. Expectedly, CT allowed a much better and more 
exact judgment of lesion distribution and severity. However, for detection of PTE the 
CT results were disappointing. For one thing, the image quality using CareDose was not 
considered optimal and post contrast CT does not fulfill the requirements for angio CT.  
 
In a second study the focus was put on newer echocardiographic modalities, i.e. Tissue 
Doppler Imaging (TDI) and contrast echo. An additional goal was to document arterio-
venous shunting during experimental infection and during therapy. It was further 
hypothesized that PH may develop right at the time of treatment, when many worms 
die. In this study, six healthy Beagles were infected with 200 L3 larvae. TDI (pulsed 
wave, RV longitudinal myocardial velocity basal segment), contrast echo with agitated 
saline and pulmonary transit time with SonoVueR, as well as invasive PAP 
measurement were performed pre infection (T0), once 7 to 12 weeks post infection (T1) 
and once during the first five days after parasiticide therapy (T2).  
Tei and TeiTDI indexes did not change over time. In the TDI variables analysed there 
was a decrease in peak myocardial velocity in systole (STDI) and an increase in time to 
peak systolic contraction (Tpeak) with a median STDI of 0.130 m/s (0.123-0.194), 0.128 
m/s (0.087-0.173) and 0.117 m/s (0.083-0.152), and a median Tpeak of 0.097 ms (0.074-
0.149), 0.109 ms (0.102-0.196) and 0.149 ms (0.104-0.234) at T0, T1, and T2, 
respectively. The E/ATDI ratio decreased from T0 1.13 (0.94-1.55) to T2 0.91 (0.54-
1.38). At T0 all dogs showed negative, and at T1 and T2 5 of 6 dogs showed positive 
contrast studies for shunts. Median pulmonary transit time was 4 beats respectively 2.3 
seconds at T0 and no change was observed at T1 and T2. Invasively measured PAP 
slightly increased over time with median sPAP of 24, 25 and 29 mmHg and dPAP of 
10, 11 and 18 mmHg, respectively. Two dogs showed mild PH at T2 (sPAP 33 and 30, 
and dPAP 20 and 25 mmHg); both had E/ATDI ?1.  
In conclusion, in dogs with marked pulmonary vascular disease, associated PTE and 
mild increase in PAP, effects on RV function were detectable using TDI but not 
conventional echo. 
In face of severe pulmonary disease the majority of dogs developed intrapulmonary 
arterio-venous shunts in the absence of relevant PH. Parasiticidal therapy did cause an 
increase in PAP, but not to a clinically relevant degree. 
For most clinicians, plasma D-dimers have become an important tool to rule-out or -in 
PTE. In the second study, we therefore measured plasma D-dimers using an 
immunoturbidimetric method (and PT, PTT, TT). None of the dogs showed relevant 
changes in PT, PTT or TT. The values for plasma D-dimers were 0.17 (0.12-0.35) 
µg/ml at T0, 0.37 (0.26-1.21) µg/ml at T1, and 0.50 (0.26-2.37) µg/ml at T2. 
Determination of D-dimers by immunoturbidometry was neither very sensitive nor 
specific to detect PTE.  
Finally, it has long been described that thoracic radiographs are neither sensitive nor 
specific to detect PTE. This view has not changed as of today. It is, indeed, very 
interesting to not that some dogs with most severe obstructive pulmonary vascular 
disease, as documented by severe pulmonary hypertension, show very unremarkable 
thoracic radiographs, whereas other dogs with most severe pulmonary changes on 
thoracic radiographs, induced by vasculitis (with potential or expected PTE), may not 
show much evidence of pulmonary vascular obstruction as documented by lack of 
clinically relevant pulmonary hypertension. Thus, even though thoracic radiographs are 
an important tool to recognize pulmonary (vascular) disease, it is the combination of 
findings, and in many cases the discrepancy between radiographic (mild) and 
ultrasonographic (severe) changes that should trigger the suspicion of PTE.  
In summary, PTE may be difficult to diagnose using non-invasive and broadly available 
examination techniques. As indicated above, probably the most important diagnostic 
clue to detect PTE is a high index of suspicion. 
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